<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29211214</article-id><article-id pub-id-type="pmc">5701099</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0040</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Hybrid Approach of Aortic Diseases: Zone 1 Delivery and Volumetric
Analysis on the Descending Aorta</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Duncan</surname><given-names>Jos&#x000e9; Augusto</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Dias</surname><given-names>Ricardo Ribeiro</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Dinato</surname><given-names>Fabr&#x000ed;cio Jos&#x000e9;</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fernandes</surname><given-names>F&#x000e1;bio</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ramirez</surname><given-names>F&#x000e9;lix Jos&#x000e9; &#x000c1;lvares</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mady</surname><given-names>Charles</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jatene</surname><given-names>Fabio Biscegli</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1">
<label>1</label> Instituto do Cora&#x000e7;&#x000e3;o do Hospital das
Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo
(InCor-HCFMUSP), S&#x000e3;o Paulo, SP, Brazil.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: Jos&#x000e9; Augusto Duncan, Instituto do
Cora&#x000e7;&#x000e3;o, Av. Dr. En&#x000e9;as de Carvalho Aguiar, 44 - bloco II,
2&#x000ba; andar, sala 13 - Pinheiros - S&#x000e3;o Paulo, SP, Brazil, Zip code:
05403-900. E-mail: <email>duncan@incor.usp.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2017</year></pub-date><volume>32</volume><issue>5</issue><fpage>361</fpage><lpage>366</lpage><history><date date-type="received"><day>03</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>27</day><month>6</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Conventional techniques of surgical correction of arch and descending aortic
diseases remains as high-risk procedures. Endovascular treatments of
abdominal and descending thoracic aorta have lower surgical risk. Evolution
of both techniques - open debranching of the arch and endovascular approach
of the descending aorta - may extend a less invasive endovascular treatment
for a more extensive disease with necessity of proximal landing zone in the
arch.</p></sec><sec><title>Objective</title><p>To evaluate descending thoracic aortic remodeling by means of volumetric
analysis after hybrid approach of aortic arch debranching and stenting the
descending aorta.</p></sec><sec><title>Methods</title><p>Retrospective review of seven consecutive patients treated between September
2014 and August 2016 for diseases of proximal descending aorta (aneurysms
and dissections) by hybrid approach to deliver the endograft at zone 1.
Computed tomography angiography were analyzed using a specific software to
calculate descending thoracic aorta volumes pre- and postoperatively.</p></sec><sec><title>Results</title><p>Follow-up was done in 100% of patients with a median time of 321 days (range,
41-625 days). No deaths or permanent neurological complications were
observed. There were no endoleaks or stent migrations. Freedom from
reintervention was 100% at 300 days and 66% at 600 days. Median volume
reduction was of 45.5 cm<sup>3</sup>, representing a median volume shrinkage
by 9.3%.</p></sec><sec><title>Conclusion</title><p>Hybrid approach of arch and descending thoracic aorta diseases is feasible
and leads to a favorable aortic remodeling with significant volume
reduction.</p></sec></abstract><kwd-group><kwd>Aorta, Thoracic</kwd><kwd>Aneurysm, Dissecting</kwd><kwd>Minimally Invasive Surgical Procedures</kwd></kwd-group></article-meta></front><body><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TEVAR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;= Thoracic endovascular
aortic repair</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Conventional techniques for surgical correction of aortic arch and descending
diseases (either aneurysms or dissections) requires extracorporeal circulation
associated with deep hypothermia and circulatory arrest. It remains as high-risk
procedures, although recent advances (pre-, intra- and postoperatively) have
improved results dramatically<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.</p><p>Endovascular treatments of abdominal and thoracic descending aorta are already
well-established and have a lower surgical risk when compared to conventional
techniques<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Improvement
of both, techniques and endoprosthesis, made endovascular management of more complex
aortic diseases, like those affecting distal arch and proximal descending aortic
segments also possible, reducing treatment morbimortality of the
procedure<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>In order to make it feasible, sophisticated vascular techniques were improved aiming
to keep cerebral perfusion. Debranching of supra-aortic vessels enables access to
healthier aortic sections, propitious to serve as landing zones to endovascular
prosthesis<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>]</sup>. This hybrid aortic arch approach
has emerged as a less invasive option, mainly to high-risk patients<sup>[<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>Giving this background, the treatment addressed to these patients consists in
performing, previously to the endoprosthesis implant, debranching of the
supra-aortic vessels to obtain at least 2 cm of healthy aorta.</p><p>The purpose of this study is to evaluate the aortic remodeling after hybrid approach
of the distal arch and proximal descending aortic diseases by means of volumetric
analysis of the descending thoracic aorta.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Patient Population</title><p>We performed a retrospective review of our single-center results of all patients
who underwent hybrid aortic repair for complex aneurysms or type B dissection
between September 2014 and August 2016. Inclusion criteria was related to any
involvement of the distal aortic arch and proximal descending aortic disease
with an inappropriate direct landing zone for Thoracic EndoVascular Aortic
Repair (TEVAR). The landing zone chosen had to be zone 1. Patients with
ascending or proximal arch pathology were excluded from the study. Data were
prospectively collected for patient demographics, indications of intervention,
risk factors, procedures and outcomes.</p><p>Seven consecutive patients underwent hybrid aortic repair, meaning double
debranching of the supra-aortic vessels in order to create a suitable proximal
landing zone to the endograft right after the origin of the innominate artery -
according to Ishimaru and Mitchell classification, zone 1<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>All patients included in this study had computed tomography angiography pre- and
postoperatively, allowing volume measurements and comparison.</p></sec><sec><title>Indications for Intervention</title><p>Patients were referred to surgery according to the European guideline for aortic
treatment<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup> - when the
largest diameter reached 55 mm, growth rate over 0.5 cm/year or when the patient
presented with symptoms.</p><p>In our series, the largest diameter ranged from 42.4 mm to 91 mm (median 60.5
mm). Only one patient had the largest diameter &#x0003c; 55 mm, a symptomatic type B
chronic dissection. In total, two (28.6%) patients were symptomatic and five
were asymptomatic (<xref ref-type="table" rid="t1">Table 1</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Indications for hybrid aortic arch intervention.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Indications for intervention</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Symptomatic</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">28.6</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Chronic dissection</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Aneurysm</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Asymptomatic</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">71.4</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Chronic dissection</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Aneurysm</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table></table-wrap><p>Considering the disease, patients with chronic dissection had diameters ranging
from 42.4 mm to 61.3 mm while patients with aneurysm had diameters from 60.1 mm
to 91 mm (<xref ref-type="table" rid="t2">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Diameters according to disease.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Disease</th><th align="center" rowspan="1" colspan="1">Diameters (mm), range</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Chronic dissection</td><td align="center" rowspan="1" colspan="1">42.4-61.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Aneurysm</td><td align="center" rowspan="1" colspan="1">60.1-91</td></tr></tbody></table></table-wrap></sec><sec><title>Debranching Procedure</title><p>All bypass procedures were performed in a hybrid operating room, with the patient
under general anesthesia and receiving intravenous heparin.</p><p>Access to and isolation of supra-aortic vessels was achieved through upper
ministernotomy (L-shaped, left second intercostal space). All patients were
submitted to double debranching, in order to make possible to anchor the
endoprosthesis at zone 1.</p><p>Left subclavian artery was approached firstly, dissecting it as far distal as
possible. It was then clamped, sectioned right after its origin and the proximal
stump carefully closed with 4-0 or 5-0 monofilament sutures. An arteriotomy was
made at the lateral side of the left common carotid artery and the end-to-side
anastomosis was performed with a 5-0 monofilament suture without tension.
Similar technique was used to anastomose the left common carotid artery to the
innominate artery (<xref ref-type="fig" rid="f1">Figures 1A</xref>, <xref ref-type="fig" rid="f1">1B</xref> and <xref ref-type="fig" rid="f1">1C</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Debranching to zone 1: scheme (A), intraoperative picture (B) and
angiography confirming patency and endograft position without
endoleaks (C). IA=innominate artery; IV=innominate vein; LCCA=left
common carotid artery; LSCA=left subclavian artery</p></caption><graphic xlink:href="rbccv-32-05-0361-g01"/></fig>
</p><p>Revascularization of the left subclavian artery was performed in every patient.
When a graft was needed (to avoid a tensioned anastomosis), a 6-mm
Dacron<sup>&#x000ae;</sup> graft (Jotec Inc., Hechingen, Germany) was used
either to achieve transposition of the left subclavian artery to the left
carotid artery (one patient, 14.3%) or to bypass the left carotid artery to the
innominate artery (two patients, 28.6%). An aortography was performed right
after the debranching procedure to confirm the patency of all supraaortic
vessels.</p></sec><sec><title>TEVAR Procedure</title><p>All TEVAR procedures were performed as standardized TEVAR protocols. Access to
the true lumen was obtained from a transfemoral approach after an inguinal
cutdown. Through a 5F pigtail catheter, a 300-cm-long stiff wire (Lunderquist,
Cook, Denmark) was placed at the ascending aorta using fluoroscopy. Another 5F
pigtail catheter was placed through the contralateral femoral artery to the
ascending aorta for repeated angiographies using 623 mg/mL iodine contrast
(Ultravist 300; Bayer Pharma AG, Germany) during the procedure.</p><p>All stent grafts were deployed in the desired position (zone 1 delivery) under
pharmacologically induced arterial hypotension, in order to avoid any windsock
effect or misplacement.</p><p>Stent graft dimensions were chosen by measuring the diameter of the proximal and
distal landing zone in an orthogonal view. This was possible after using a
workstation to reformat the computed tomography angiography. In patients
presenting with aortic dissection, no oversizing was done. Oversizing more than
20% was avoided when dealing with aneurysms. Balloon dilatation was only
performed when a residual endoleak was noticed in dissections and always when
treating aneurysms.</p><p>The three patients presenting with chronic type B aortic dissections were treated
with one single endograft of 200 mm and the four other patients presenting with
descending thoracic aorta aneurysms received up to three endografts, with a
maximum coverage length of 330 mm (<xref ref-type="table" rid="t3">Table
3</xref>).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Procedural data from TEVAR.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="70%" span="1"/><col width="10%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Intraoperative characteristics</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Double debranching (zone 1)</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">100</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of Dacron<sup>&#x000ae;</sup> graft to
debranch</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">42.9</td></tr><tr><td align="left" rowspan="1" colspan="1">LSCA-LCCA</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">LCCA-IA</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">One-stage procedure</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">85.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of endoprosthesis</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">71.4</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">14.3</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">14.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Occlusion of left subclavian artery</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Insertion through femoral artery</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">100</td></tr><tr><td align="left" rowspan="1" colspan="1">Proximal diameter of first endograft (median,
mm)</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">(range 32-46)</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of stents (median)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">(range 1-3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Total coverage length (median, mm)</td><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1">(range 200-330)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>IA=innominate artery; LCCA=left common carotid artery; LSCA=left
subclavian artery</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Volume Measurement</title><p>All seven patients underwent a thin-cut (1- to 3-mm slices),
electrocardiograph-gated computed tomography angiography both pre- and
postoperatively. Axial static images were manipulated to multiplanar and
tridimensional reconstructions in order to make more accurate measures. Those
mensurations were made by the surgeons.</p><p>On consecutive cross-sectional images, a series of individually placed points
created an outline margin of the total aorta (<xref ref-type="fig" rid="f2">Figure 2A</xref>). These delimitations were placed at every 1- to 3-mm
distance from one another. Anatomical references for beginning and ending of the
thoracic aorta were the left subclavian artery origin and celiac trunk origin.
Volumetric measurements for the total descending thoracic aorta were then
calculated as the sum of this series of irregular 1- to 3-mm-height cylinders
(<xref ref-type="fig" rid="f2">Figure 2B</xref>). All volumes were expressed
in cm<sup>3</sup>.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Steps of volume calculation: individually placed points delimitates
the outer margin of total aorta at each axial image (A); resulting
three-dimensional reconstruction (B).</p></caption><graphic xlink:href="rbccv-32-05-0361-g02"/></fig>
</p></sec><sec><title>Follow-up</title><p>The protocol included a computed tomography angiography that was requested at
first appointment after hospital discharge and annually thereafter.</p></sec><sec><title>Definitions and Statistical Analysis</title><p>Technical success was defined as patency of supra-aortic vessels associated with
correct position of the endograft and absence of endoleaks. Outcome criteria
were defined according to the reporting standards for TEVAR<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. The results were expressed as
mean, median and standard deviations of continuous variables and frequencies and
percentage frequencies of categoric factors. Analysis was done with Google
Sheets (Google Inc., Palo Alto, CA, USA) and with Kaplan-Meier Survival Curve
Grapher (Eureka Statistics - Peter Rosenmai, <ext-link ext-link-type="uri" xlink:href="http://eurekastatistics.com/kaplan-meier-survival-curve-grapher/">http://eurekastatistics.com/kaplan-meier-survival-curve-grapher/</ext-link>).</p><p>Measures and volume calculation pre- and postoperative were done through Horos
software (Horos Project - DICOM image viewing and measuring. <ext-link ext-link-type="uri" xlink:href="http://www.horosproject.org/">http://www.horosproject.org/</ext-link>). When patients had more than one
postoperative computed tomography angiography, the last one was used.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Preoperative patient characteristics and indications for hybrid aortic repair are
described in <xref ref-type="table" rid="t1">Tables 1</xref> and <xref ref-type="table" rid="t4">4</xref>, respectively.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Baseline characteristics of patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="60%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Mean age, &#x000b1; SD, years</td><td align="center" rowspan="1" colspan="1">62.2&#x000b1;5.0</td><td align="center" rowspan="1" colspan="1">Range 55-68</td></tr><tr><td align="left" rowspan="1" colspan="1">Males</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">71.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">85.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">14.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyperlipidemia</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">57.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic renal disease</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic renal disease, dialytic</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Acute renal disease</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoker</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">100</td></tr><tr><td align="left" rowspan="1" colspan="1">COPD</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">14.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Family history</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Dyspepsia</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke with deficits</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke without deficits</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">HIV</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Cancer</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">14.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Coronary artery disease</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">42.8</td></tr><tr><td align="left" rowspan="1" colspan="1">History of heart attack</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">14.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Thoracic pain</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">28.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Marfan syndrome</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Bicuspid aortic valve</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrial fibrillation</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">14.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Alcohol abuse</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">28.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Obesity (BMI &#x0003e; 30)</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">42.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Elective</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">42.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Urgent repair</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">57.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Aneurysm</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">57.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Acute type B dissection</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic type B dissection</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">42.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal ventricular function (EF &#x02265; 55%)</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">85.7</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>BMI=body mass index; COPD=chronic obstructive pulmonary disease;
EF=ejection fraction; HIV=human immunodeficiency virus; SD=standard
deviation</p></fn></table-wrap-foot></table-wrap><p>Our population had hyperlipidemia in four (57.2%) patients, hypertension in six
(85.7%) and history of smoking in all of them. Three (42.9%) patients were secondary
of increasing in size of the aortic dissection and four (57.1%) secondary to aortic
aneurysm. Two (28.5%) patients were symptomatic, referring thoracic pain - one had
aneurysm and the other had chronic dissection.</p><p>Procedural data from TEVAR are summarized in <xref ref-type="table" rid="t3">Table
3</xref>. Two commercially available endoprosthesis were used, according to the
availability in our institution. They comprised both Valiant Captivia (Medtronic,
Minneapolis, MN, USA) in six (85.7%) patients and Gore TAG (W.L. Gore &#x00026;
Associates, Inc., Flagstaff, AZ, USA) in one (14.3%).</p><p>Follow-up was done in 100% of patients with a median time of 321 days (range 41-625
days). Technical success was achieved in all patients, with long-term patency of
supra-aortic vessels, correct positioning of endoprosthesis and neither endoleaks
nor migrations observed. Those items were documented through postoperative computed
tomography angiography that was done at a median postoperative time of 286 days
(range 38-572). There were no deaths.</p><p>Considering all complications following TEVAR in this study, one patient presented
postoperatively with an aneurysm that grew in extension, despite of the absence of
any visible endoleaks at the intraprocedural angiography. This growth was detected
at the first postprocedural computed tomography angiography, performed after the
outpatient return. We treated implanting a second endoprosthesis, increasing the
coverage length. A computed tomography angiography performed 5 days postoperatively,
before hospital discharge, demonstrated a reduction of 28.4 cm<sup>3</sup>,
representing a decrease of 4.8%. This patient was the only one who required a
reintervention, with freedom of reintervention in 100% at 300 days and 66% at 600
days.</p><p>Three (42.9%) patients presented with acute renal failure, defined in our study as a
serum creatinine elevation of at least 0.5 mg/dL. None of them needed hemodialysis.
No strokes with permanent deficits were detected, although one patient presented
with a left facial paralysis that was completely resolved spontaneously after three
days. A cranial computed tomography was done with no specific findings. There were
also no permanent paraplegia even though one patient had transient symptoms
attributed to medullary ischemia (lower limbs weakness and urinary retention). No
major pulmonary problem was observed. No patients presented with retrograde type A
dissection, access site complications, mesenteric ischemia or wound infections.</p><p>TEVAR was done simultaneously to the debranching procedure in 85.7% (6 patients). We
performed a staged procedure in one patient because of some atherosclerotic plaques
noticed at the debranching procedure. It was considered safer to observe if there
would be any neurological deficit before the endograft implant.</p><p>Analysis of aortic morphology began with multiplanar and three-dimensional
reconstruction to better define the anatomic limits to volume calculation of the
total aorta. When comparing pre- and postoperative volumes it was noticed a median
reduction of 45.5 cm<sup>3</sup>, representing a median shrinkage of 9.3%.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>It is known that the majority of thoracic aortic diseases are degenerative and occur
in association with risk factors for atherosclerosis such as smoking, hypertension
and hypercholesterolemia<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup> and
all of those had a high prevalence in our sample.</p><p>One of the factors that impact morbimortality after aortic interventions are
neurologic events and progression of aortic disease<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. TEVAR is a safe and effective procedure to treat
both aneurysms and dissections involving the descending aorta with relative low
risk<sup>[<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref>]</sup>. The landing zone was soon extended proximally in
order to treat more extensive segments of the aorta, reducing the morbimortality
when compared with conventional techniques<sup>[<xref rid="r14" ref-type="bibr">14</xref>-<xref rid="r16" ref-type="bibr">16</xref>]</sup>.</p><p>New totally endovascular techniques for treatment of complex aortic arch diseases are
available and include stenting of the supra-aortic vessels (parallel techniques),
fenestrated or branched endografts. Those are promising, but experience in aortic
arch repair are very limited<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>
and we do not have them available for patients from the public health system.</p><p>Supra-aortic debranching is by itself a safe surgical procedure with a low
complication rate<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. In our
study, no perioperative deaths, complications for local reasons or left recurrent
laryngeal nerve injury occurred.</p><p>Stroke with permanent deficits did not occur in our patients. Nevertheless, it is a
major concern since it can be the result of manipulation of the supra-aortic vessels
while debranching or of embolism formation secondary to wire manipulation during
TEVAR<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Spinal cord
injury is also a significant problem, related to the extent of endograft
coverage<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. In our
study, transient symptoms related to spinal cord ischemia happened to the patient
with the largest coverage length (330 mm, from left carotid artery to just above the
celiac trunk emergence).</p><p>Endoleaks after TEVAR are observed<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>, with up to 42% of incidence<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. Although early endoleaks were not observed in
our study, one patient had an aneurysm growth and needed a second procedure.</p><p>Reintervention was necessary in one (14.3%) patient after almost one year (321 days)
and the technical success rate for this secondary procedure was 100%. This
information highlights the need for a close surveillance in all patients after
TEVAR, which is very challenging in a developing country with continental dimensions
like Brazil.</p><p>At present, few data are available on volumetric outcomes of hybrid aortic procedures
despite of its documented better sensitiveness to aneurysm size change when compared
to diameter<sup>[<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r22" ref-type="bibr">22</xref>]</sup>. Volumetric calculation varies according to
operator experience<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup> and
although the median reduction in our series was found to be of 9.3%, there is a
potential measurement error of 10%<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. Time of follow-up must be also considered since remodeling
continues up to five years<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>.
When only patients with more than 250 days of follow-up were taken into account,
median shrinkage rose to 13.5%. Furthermore, every patient of our study had
thrombosis around the endoprosthesis, what has correlation with shrinkage<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>.</p><p>Despite the fact that this is a report of an initial experience in treating this
extension of aortic disease and following up with volumetric analysis, it also must
be said that the limitations of this study includes not only the reduced number of
patients, but also the short follow-up time.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Hybrid aortic zone 1 proximal delivery of endograft is a viable alternative to
conventional aortic arch surgery in patients with both aneurysms and type B
dissections. It leads to a favorable aortic remodeling that continues to improve
over time. Further studies with a larger sample and longer follow-up are needed to
confirm this idea.</p><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">JAD</td><td align="left" valign="top" rowspan="1" colspan="1">Agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RRD</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FJD</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FF</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FJAR</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CM</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FBJ</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at Instituto do Cora&#x000e7;&#x000e3;o do Hospital das
Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo
(InCor-HCFMUSP), S&#x000e3;o Paulo, SP, Brazil.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shijo</surname><given-names>T</given-names></name><name><surname>Kuratani</surname><given-names>T</given-names></name><name><surname>Torikai</surname><given-names>K</given-names></name><name><surname>Shimamura</surname><given-names>K</given-names></name><name><surname>Sakamoto</surname><given-names>T</given-names></name><name><surname>Kudo</surname><given-names>T</given-names></name><etal/></person-group><article-title>Thoracic endovascular aortic repair for degenerative distal arch
aneurysm can be used as a standard procedure in high-risk
patients</article-title><source>Eur J Cardiothorac Surg</source><year>2016</year><volume>50</volume><issue>2</issue><fpage>257</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">26850267</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dua</surname><given-names>A</given-names></name><name><surname>Andre</surname><given-names>J</given-names></name><name><surname>Nolte</surname><given-names>N</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Hood</surname><given-names>D</given-names></name><name><surname>Hodgson</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>The impact of physician specialization on clinical and hospital
outcomes in patients undergoing EVAR and TEVAR</article-title><source>Ann Vasc Surg</source><year>2016</year><volume>35</volume><fpage>138</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">27238978</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottardi</surname><given-names>R</given-names></name><name><surname>Seitelberger</surname><given-names>R</given-names></name><name><surname>Zimpfer</surname><given-names>D</given-names></name><name><surname>Lammer</surname><given-names>J</given-names></name><name><surname>Wolner</surname><given-names>E</given-names></name><name><surname>Grimm</surname><given-names>M</given-names></name><etal/></person-group><article-title>An alternative approach in treating an aortic arch aneurysm with
an anatomic variant by supraaortic reconstruction and stent-graft
placement</article-title><source>J Vasc Surg</source><year>2005</year><volume>42</volume><issue>2</issue><fpage>357</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">16102640</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czerny</surname><given-names>M</given-names></name><name><surname>Schmidli</surname><given-names>J</given-names></name><name><surname>Carrel</surname><given-names>T</given-names></name><name><surname>Grimm</surname><given-names>M</given-names></name></person-group><article-title>Hybrid aortic arch repair</article-title><source>Ann Cardiothorac Surg</source><year>2013</year><volume>2</volume><issue>3</issue><fpage>372</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">23977610</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buth</surname><given-names>J</given-names></name><name><surname>Penn</surname><given-names>O</given-names></name><name><surname>Tielbeek</surname><given-names>A</given-names></name><name><surname>Mersman</surname><given-names>M</given-names></name></person-group><article-title>Combined approach to stent-graft treatment of an aortic arch
aneurysm</article-title><source>J Endovasc Surg</source><year>1998</year><volume>5</volume><issue>4</issue><fpage>329</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">9867322</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lotfi</surname><given-names>S</given-names></name><name><surname>Clough</surname><given-names>RE</given-names></name><name><surname>Ali</surname><given-names>T</given-names></name><name><surname>Salter</surname><given-names>R</given-names></name><name><surname>Young</surname><given-names>CP</given-names></name><name><surname>Bell</surname><given-names>R</given-names></name><etal/></person-group><article-title>Hybrid repair of complex thoracic aortic arch pathology:
long-term outcomes of extra-anatomic bypass grafting of the supra-aortic
trunk</article-title><source>Cardiovasc Intervent Radiol</source><year>2013</year><volume>36</volume><issue>1</issue><fpage>46</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">22526104</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>RS</given-names></name><name><surname>Ishimaru</surname><given-names>S</given-names></name><name><surname>Ehrlich</surname><given-names>MP</given-names></name><name><surname>Iwase</surname><given-names>T</given-names></name><name><surname>Lauterjung</surname><given-names>L</given-names></name><name><surname>Shimono</surname><given-names>T</given-names></name><etal/></person-group><article-title>First International Summit on Thoracic Aortic Endografting:
roundtable on thoracic aortic dissection as an indication for
endografting</article-title><source>J Endovasc Ther</source><year>2002</year><volume>9</volume><issue>suppl. 2</issue><fpage>II98</fpage><lpage>II105</lpage><pub-id pub-id-type="pmid">12166849</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erbel</surname><given-names>R</given-names></name><name><surname>Aboyans</surname><given-names>V</given-names></name><name><surname>Boileau</surname><given-names>C</given-names></name><name><surname>Bossone</surname><given-names>E</given-names></name><name><surname>Di Bartolomeo</surname><given-names>R</given-names></name><name><surname>Eggebrecht</surname><given-names>H</given-names></name><etal/></person-group><article-title>2014 ESC Guidelines on the diagnosis and treatment of aortic
diseases: Document covering acute and chronic aortic diseases of the
thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis
and Treatment of Aortic Diseases of the European Society of Cardiology
(ESC)</article-title><source>Eur Heart J</source><year>2014</year><volume>35</volume><issue>41</issue><fpage>2873</fpage><lpage>2926</lpage><pub-id pub-id-type="pmid">25173340</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fillinger</surname><given-names>MF</given-names></name><name><surname>Greenberg</surname><given-names>RK</given-names></name><name><surname>McKinsey</surname><given-names>JF</given-names></name><name><surname>Chaikof</surname><given-names>EL</given-names></name><collab>Society for Vascular Surgery Ad Hoc Committee on TEVAR Reporting
Standards</collab></person-group><article-title>Reporting standards for thoracic endovascular aortic repair
(TEVAR)</article-title><source>J Vasc Surg</source><year>2010</year><volume>52</volume><issue>4</issue><fpage>1022</fpage><lpage>1033</lpage><pub-id pub-id-type="pmid">20888533</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isselbacher</surname><given-names>EM</given-names></name></person-group><article-title>Thoracic and abdominal aortic aneurysms</article-title><source>Circulation</source><year>2005</year><volume>111</volume><issue>6</issue><fpage>816</fpage><lpage>828</lpage><pub-id pub-id-type="pmid">15710776</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ullery</surname><given-names>BW</given-names></name><name><surname>McGarvey</surname><given-names>M</given-names></name><name><surname>Cheung</surname><given-names>AT</given-names></name><name><surname>Fairman</surname><given-names>RM</given-names></name><name><surname>Jackson</surname><given-names>BM</given-names></name><name><surname>Woo</surname><given-names>EY</given-names></name><etal/></person-group><article-title>Vascular distribution of stroke and its relationship to
perioperative mortality and neurologic outcome after thoracic endovascular
aortic repair</article-title><source>J Vasc Surg</source><year>2012</year><volume>56</volume><issue>6</issue><fpage>1510</fpage><lpage>1517</lpage><pub-id pub-id-type="pmid">22841287</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nienaber</surname><given-names>CA</given-names></name><name><surname>Fattori</surname><given-names>R</given-names></name><name><surname>Lund</surname><given-names>G</given-names></name><name><surname>Dieckmann</surname><given-names>C</given-names></name><name><surname>Wolf</surname><given-names>W</given-names></name><name><surname>von Kodolitsch</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Nonsurgical reconstruction of thoracic aortic dissection by
stent-graft placement</article-title><source>N Engl J Med</source><year>1999</year><volume>340</volume><issue>20</issue><fpage>1539</fpage><lpage>1545</lpage><pub-id pub-id-type="pmid">10332015</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svensson</surname><given-names>LG</given-names></name><name><surname>Kouchoukos</surname><given-names>NT</given-names></name><name><surname>Miller</surname><given-names>DC</given-names></name><name><surname>Bavaria</surname><given-names>JE</given-names></name><name><surname>Coselli</surname><given-names>JS</given-names></name><name><surname>Curi</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Expert consensus document on the treatment of descending thoracic
aortic disease using endovascular stent-grafts</article-title><source>Ann Thorac Surg</source><year>2008</year><volume>85</volume><issue>1 suppl.</issue><fpage>S1</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">18083364</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eagleton</surname><given-names>MJ</given-names></name><name><surname>Greenberg</surname><given-names>RK</given-names></name></person-group><article-title>Hybrid procedures for the treatment of aortic arch
aneurysms</article-title><source>J Cardiovasc Surg</source><year>2010</year><volume>51</volume><issue>6</issue><fpage>807</fpage><lpage>819</lpage><pub-id pub-id-type="pmid">21124277</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingrund</surname><given-names>JC</given-names></name><name><surname>Nasser</surname><given-names>F</given-names></name><name><surname>Jesus-Silva</surname><given-names>SG</given-names></name><name><surname>Limaco</surname><given-names>RP</given-names></name><name><surname>Galastri</surname><given-names>FL</given-names></name><name><surname>Burihan</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Hybrid procedures for complex thoracic aortic
diseases</article-title><source>Rev Bras Cir Cardiovasc</source><year>2010</year><volume>25</volume><issue>3</issue><fpage>303</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">21103737</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzger</surname><given-names>PB</given-names></name><name><surname>Rossi</surname><given-names>FH</given-names></name><name><surname>Moreira</surname><given-names>SM</given-names></name><name><surname>Issa</surname><given-names>M</given-names></name><name><surname>Izukawa</surname><given-names>NM</given-names></name><name><surname>Dinkhuysen</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Hybrid treatment of aortic arch disease</article-title><source>Rev Bras Cir Cardiovasc</source><year>2014</year><volume>29</volume><issue>4</issue><fpage>527</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">25714205</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>HY</given-names></name><name><surname>Zou</surname><given-names>JJ</given-names></name><name><surname>Zhang</surname><given-names>XW</given-names></name></person-group><article-title>Management with the insufficient proximal landing zone for
endovascular repair in aortic dissection</article-title><source>Chin Med J</source><year>2011</year><volume>124</volume><issue>19</issue><fpage>3003</fpage><lpage>3007</lpage><pub-id pub-id-type="pmid">22040544</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrne</surname><given-names>J</given-names></name><name><surname>RC 3rd</surname><given-names>Darling</given-names></name><name><surname>Roddy</surname><given-names>SP</given-names></name><name><surname>Mehta</surname><given-names>M</given-names></name><name><surname>Paty</surname><given-names>PS</given-names></name><name><surname>Kreienberg</surname><given-names>PB</given-names></name><etal/></person-group><article-title>Long term outcome for extra-anatomic arch reconstruction. An
analysis of 143 procedures</article-title><source>Eur J Vasc Endovasc Surg</source><year>2007</year><volume>34</volume><issue>4</issue><fpage>444</fpage><lpage>450</lpage><pub-id pub-id-type="pmid">17689113</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milewski</surname><given-names>RK</given-names></name><name><surname>Szeto</surname><given-names>WY</given-names></name><name><surname>Pochettino</surname><given-names>A</given-names></name><name><surname>Moser</surname><given-names>GW</given-names></name><name><surname>Moeller</surname><given-names>P</given-names></name><name><surname>Bavaria</surname><given-names>JE</given-names></name></person-group><article-title>Have hybrid procedures replaced open aortic arch reconstruction
in high-risk patients? A comparative study of elective open arch debranching
with endovascular stent graft placement and conventional elective open total
and distal aortic arch reconstruction</article-title><source>J Thorac Cardiovasc Surg</source><year>2010</year><volume>140</volume><issue>3</issue><fpage>590</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">20723729</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nienaber</surname><given-names>CA</given-names></name><name><surname>Kische</surname><given-names>S</given-names></name><name><surname>Zeller</surname><given-names>T</given-names></name><name><surname>Rehders</surname><given-names>TC</given-names></name><name><surname>Schneider</surname><given-names>H</given-names></name><name><surname>Lorenzen</surname><given-names>B</given-names></name><etal/></person-group><article-title>Provisional extension to induce complete attachment after
stentgraft placement in type B aortic dissection: the PETTICOAT
concept</article-title><source>J Endovasc Ther</source><year>2006</year><volume>13</volume><issue>6</issue><fpage>738</fpage><lpage>746</lpage><pub-id pub-id-type="pmid">17154712</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoniou</surname><given-names>GA</given-names></name><name><surname>Mireskandari</surname><given-names>M</given-names></name><name><surname>Bicknell</surname><given-names>CD</given-names></name><name><surname>Cheshire</surname><given-names>NJ</given-names></name><name><surname>Gibbs</surname><given-names>RG</given-names></name><name><surname>Hamady</surname><given-names>M</given-names></name><etal/></person-group><article-title>Hybrid repair of the aortic arch in patients with extensive
aortic disease</article-title><source>Eur J Vasc Endovasc Surg</source><year>2010</year><volume>40</volume><issue>6</issue><fpage>715</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">20920861</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KM</given-names></name><name><surname>Donayre</surname><given-names>CE</given-names></name><name><surname>Reynolds</surname><given-names>TS</given-names></name><name><surname>Kopchok</surname><given-names>GE</given-names></name><name><surname>Walot</surname><given-names>I</given-names></name><name><surname>Chauvapun</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Aortic remodeling, volumetric analysis, and clinical outcomes of
endoluminal exclusion of acute complicated type B thoracic aortic
dissections</article-title><source>J Vasc Surg</source><year>2011</year><volume>54</volume><issue>2</issue><fpage>316</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">21819922</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caldwell</surname><given-names>DP</given-names></name><name><surname>Pulfer</surname><given-names>KA</given-names></name><name><surname>Jaggi</surname><given-names>GR</given-names></name><name><surname>Knuteson</surname><given-names>HL</given-names></name><name><surname>Fine</surname><given-names>JP</given-names></name><name><surname>Pozniak</surname><given-names>MA</given-names></name></person-group><article-title>Aortic aneurysm volume calculation: effect of operator
experience</article-title><source>Abdom Imaging</source><year>2005</year><volume>30</volume><issue>3</issue><fpage>259</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">15688106</pub-id></element-citation></ref></ref-list></back></article>